Press release
Exclusive speaker interview with iVeena released for 3rd Ophthalmic Drugs Conference
3rd Annual Ophthalmic Drugs
Europe’s leading Ophthalmic Drugs conference will explore new discoveries in the treatment of ocular rare disease, innovations in gene therapy, the challenges in drug delivery through a complex barrier, patient comfort and regulatory compliance which make up such core components within the Ophthalmic Drug sphere.
In the run up to the conference, SMi Group caught up with Mike Burr, Vice President of Product Development at iVeena, to discuss his upcoming presentation and his thoughts on the current challenges and opportunities in Ophthalmic Drug development.
A snapshot of Mike Burr’s interview:
Q. The ophthalmic novel drug delivery market has matured greatly over recent years, what are the key significant developments you have noticed over the past year?
A. “For decades now there has been research in both academia and industry into longer term (beyond one day) sustained delivery technologies for direct ocular applications with minimal translation into commercial products. Regulatory approvals by the FDA in the last year in the post-cataract space for treatments intended to replace daily anti-inflammatory eye drops is very exciting. There is also a robust pipeline of sustained delivery glaucoma therapies which could provide chronic IOP lowering capabilities in the near term.”
Q. What do you personally see as the greatest challenge to overcome in ophthalmic drug delivery at the moment?
A. “Now that we are seeing the commercialisation of small molecule sustained release products, with hopefully more to come in the near term, the next frontier is in biologics. Large molecule stability for controlled release applications is a tough one.”
The full speaker interview and more content including the latest brochure and past attendees can be found in the DOWNLOADS section on the website at www.ophthalmicdrugs.com/openpr
Sponsored by:
EXPERIMENTICA | ProMed Pharma
Contacts:
Sponsorship, exhibition and branding packages: Alia Malick +44 (0)20 7827 6168 / amalick@smi-online.co.uk
Delegate enquiries: Kieran Ronaldson on +44 (0) 20 7827 6744 / kronadlson@smi-online.co.uk
Media enquiries contact Neill Howard +44 (0) 207 827 6164 / nhoward@smi-online.co.uk
SMi Group Ltd
India House
45 Curlew Street
London
SE1 2ND
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exclusive speaker interview with iVeena released for 3rd Ophthalmic Drugs Conference here
News-ID: 1804901 • Views: …
More Releases from SMi Group
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK.
The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines.
Darren Green, Director of Computational Chemistry at GSK will be chairing at…
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety.
SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA.
The 2022 Conference theme is…
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022.
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering…
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.
Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022.
This event will convene on February 9th – 10th 2022,…
More Releases for Ophthalmic
Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market: Powering I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Ophthalmic Drugs Market Through 2025?
In recent years, the ophthalmic drugs market has witnessed robust growth. It is projected to escalate from $39.36 billion in 2024 to $42.25 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The growth…
Prominent Ophthalmic Knives Market Trend for 2025: Innovative Developments In Op …
Which drivers are expected to have the greatest impact on the over the ophthalmic knives market's growth?
The increasing prevalence of eye-related conditions is expected to boost the ophthalmic knives market. Conditions such as cataracts, glaucoma, and diabetic retinopathy are rising due to aging populations and lifestyle changes. Ophthalmic knives are used in surgeries to treat these conditions, helping to improve vision and manage eye health. The CDC's January 2024 report…
Ophthalmic Devices Market
According to the report, the global ophthalmic devices market garnered $32.53 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.0% from 2020 to 2027.
Drivers, restraints, and opportunities-
Increase in adoption of digital devices in health care sector and technological advancement in the ophthalmic devices drive the growth of the global ophthalmic devices market. However, lack of sled professional and low awareness regarding eye-related…
Ophthalmic Packaging Market Report 2024 - Ophthalmic Packaging Market Trends And …
"The Business Research Company recently released a comprehensive report on the Global Ophthalmic Packaging Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Ophthalmic Lasers Market - Empowering Progress, Shaping Eye Care Excellence: Rev …
Newark, New Castle, USA - new report, titled Ophthalmic Lasers Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ophthalmic Lasers market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ophthalmic Lasers market. The report offers an overview of the market, which…
Ophthalmic Eye Shield Market Segmentation By Material type Aluminium Ophthalmic …
Eye shields are advised for use in the eye while a periorbital surgery to avoid any injury to the globe. Ophthalmic eye shields are used for postoperative ocular protection. Ophthalmic eye shields protect the cornea and retina while any eye surgery or laser treatment. Ophthalmic eye shields are highly preferred for cataract surgeries in the elder population and blepharitis correction especially for children. According to WHO, The World Health Organization,…
